These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22269174)

  • 1. Determination and control of TEMPO, a potentially genotoxic free radical reagent used in the synthesis of filibuvir.
    Strohmeyer HE; Sluggett GW
    J Pharm Biomed Anal; 2012 Mar; 62():216-9. PubMed ID: 22269174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an LC-MS method for ultra trace-level determination of 2,2,6,6-tetramethylpiperidine-1-oxl (TEMPO), a potential genotoxic impurity within active pharmaceutical ingredients.
    Pennington J; Cohen RD; Tian Y; Boulineau F
    J Pharm Biomed Anal; 2015 Oct; 114():488-92. PubMed ID: 25921639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filibuvir, a non-nucleoside NS5B polymerase inhibitor for the potential oral treatment of chronic HCV infection.
    Beaulieu PL
    IDrugs; 2010 Dec; 13(12):938-48. PubMed ID: 21154154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical study of the comparative inhibition of hepatitis C virus RNA polymerase by VX-222 and filibuvir.
    Yi G; Deval J; Fan B; Cai H; Soulard C; Ranjith-Kumar CT; Smith DB; Blatt L; Beigelman L; Kao CC
    Antimicrob Agents Chemother; 2012 Feb; 56(2):830-7. PubMed ID: 22143520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational study on the drug resistance mechanism of HCV NS5B RNA-dependent RNA polymerase mutants V494I, V494A, M426A, and M423T to Filibuvir.
    Wang H; Guo C; Chen BZ; Ji M
    Antiviral Res; 2015 Jan; 113():79-92. PubMed ID: 25449363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity of the hepatitis C virus polymerase inhibitor filibuvir in genotype 1-infected patients.
    Wagner F; Thompson R; Kantaridis C; Simpson P; Troke PJ; Jagannatha S; Neelakantan S; Purohit VS; Hammond JL
    Hepatology; 2011 Jul; 54(1):50-9. PubMed ID: 21488067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a sensitive GC-MS method for the determination of alkylating agent, 4-chloro-1-butanol, in active pharmaceutical ingredients.
    Harigaya K; Yamada H; Yaku K; Nishi H; Haginaka J
    Chem Pharm Bull (Tokyo); 2014; 62(4):395-8. PubMed ID: 24695350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective quantitation of B
    Shamirian A; Foti C; Mitchell SS
    J Pharm Biomed Anal; 2021 May; 198():113987. PubMed ID: 33684830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a sensitive method for alkyl sulfonate genotoxic impurities determination in drug substances using gas chromatography coupled to triple quadrupole mass spectrometry.
    Liu Z; Fan H; Zhou Y; Qian X; Tu J; Chen B; Duan G
    J Pharm Biomed Anal; 2019 May; 168():23-29. PubMed ID: 30784886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase 2 study of filibuvir in combination with pegylated IFN alfa and ribavirin for chronic HCV.
    Rodriguez-Torres M; Yoshida EM; Marcellin P; Srinivasan S; Purohit VS; Wang C; Hammond JL
    Ann Hepatol; 2014; 13(4):364-75. PubMed ID: 24927607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of genotoxic epoxide at trace level in drug substance by direct injection GC/MS.
    Chen L; Zhang W; Hu S
    J Pharm Biomed Anal; 2017 Nov; 146():103-108. PubMed ID: 28873359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-residue method for pesticides analysis in green coffee beans using gas chromatography-negative chemical ionization mass spectrometry in selective ion monitoring mode.
    Pizzutti IR; de Kok A; Dickow Cardoso C; Reichert B; de Kroon M; Wind W; Weber Righi L; Caiel da Silva R
    J Chromatogr A; 2012 Aug; 1251():16-26. PubMed ID: 22771261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay at low ppm level of dimethyl sulfate in starting materials for API synthesis using derivatization in ionic liquid media and LC-MS.
    Grinberg N; Albu F; Fandrick K; Iorgulescu E; Medvedovici A
    J Pharm Biomed Anal; 2013 Mar; 75():1-6. PubMed ID: 23312378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a sensitive GC-MS method for the determination of trace levels of an alkylating reagent in a beta-lactam active pharmaceutical ingredient.
    Li H; Sluggett GW
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):486-94. PubMed ID: 15951149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous Determination of Genotoxic Impurities in Fudosteine Drugs by GC-MS.
    Gooty AR; Katreddi HR; S RR; Hunnur RK; Sharma HK; Masani NK
    J Chromatogr Sci; 2016 Sep; 54(8):1277-81. PubMed ID: 27261527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scavenging with TEMPO* to identify peptide- and protein-based radicals by mass spectrometry: advantages of spin scavenging over spin trapping.
    Wright PJ; English AM
    J Am Chem Soc; 2003 Jul; 125(28):8655-65. PubMed ID: 12848573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of residual isobutylene oxide--a genotoxic starting material in a drug substance by static headspace gas chromatography.
    Han J; Yeung D; Wang F; Semin D
    J Chromatogr Sci; 2008 Aug; 46(7):637-42. PubMed ID: 18718141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of chromatographic methods for the determination of genotoxic impurities in cloperastine fendizoate.
    García A; Rupérez FJ; Ceppa F; Pellati F; Barbas C
    J Pharm Biomed Anal; 2012 Mar; 61():230-6. PubMed ID: 22226040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative determination of potential genotoxic impurity 3-aminopyridine in linagliptin active pharmaceutical ingredient using HILIC-UV.
    Al-Sabti B; Harbali J
    Biomed Chromatogr; 2020 Nov; 34(11):e4930. PubMed ID: 32579716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation behavior of a bifunctional tempo-active ester reagent for peptide structure analysis by free radical initiated peptide sequencing (FRIPS) mass spectrometry.
    Ihling C; Falvo F; Kratochvil I; Sinz A; Schäfer M
    J Mass Spectrom; 2015 Feb; 50(2):396-406. PubMed ID: 25800022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.